{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:26:54Z","timestamp":1788323214870,"version":"build-2803163510"},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jiac.2024.08.003","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T16:04:33Z","timestamp":1722960273000},"page":"102488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Two cases of iatrogenic levofloxacin-resistant pre-XDR tuberculosis in Japan"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-0110","authenticated-orcid":false,"given":"Tomohiko","family":"Ukai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ohkado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7278-8816","authenticated-orcid":false,"given":"Takashi","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.08.003_bib2","first-page":"41","article-title":"Management of patients with multidrug-resistant\/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement","volume":"44","author":"Chang","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2024.08.003_bib3","series-title":"Centers for disease control and prevention","article-title":"Drug-resistant TB","author":"Cdctb","year":"2024"},{"key":"10.1016\/j.jiac.2024.08.003_bib5","first-page":"1129","article-title":"Drug-resistant Mycobacterium tuberculosis in Japan: a nationwide survey, 2002","volume":"11","year":"2007","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2024.08.003_bib6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JCM.05638-11","article-title":"Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis","volume":"50","author":"Mitarai","year":"2012","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.jiac.2024.08.003_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jinf.2012.02.012","article-title":"Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB\/RIF assay: a meta-analysis","volume":"64","author":"Chang","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2024.08.003_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102199","article-title":"Clinical evaluation of the cobas\u00ae MTB-RIF\/INH reagent and the cobas\u00ae 6800 for the detection of isoniazid and rifampicin resistance","volume":"134","author":"Aono","year":"2022","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jiac.2024.08.003_bib9","unstructured":"WHO updates its treatment guidelines for multidrug- and rifampicin-resistant tuberculosis. [cited 19 Apr 2024]. Available: https:\/\/www.who.int\/news\/item\/22-12-2018-who-updates-its-treatment-guidelines-for-multidrug--and-rifampicin-resistant-tuberculosis."},{"key":"10.1016\/j.jiac.2024.08.003_bib10","first-page":"127","article-title":"Drug selection at the initiation of tuberculosis treatment considering the presence or absence of resistance gene testing","volume":"98","year":"2023","journal-title":"Kekkaku"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:43:01Z","timestamp":1736768581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24002125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1341321X24002125"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.08.003","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two cases of iatrogenic levofloxacin-resistant pre-XDR tuberculosis in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102488"}}